- Home
- VNRX vs CXH Comparison
VNRX vs CXH Comparison
Compare VNRX & CXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- CXH
- Stock Information
- Founded
- VNRX N/A
- CXH 1989
- Country
- VNRX United States
- CXH United States
- Employees
- VNRX N/A
- CXH N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CXH Investment Managers
- Sector
- VNRX Health Care
- CXH Finance
- Exchange
- VNRX Nasdaq
- CXH Nasdaq
- Market Cap
- VNRX 52.4M
- CXH 62.0M
- IPO Year
- VNRX N/A
- CXH N/A
- Fundamental
- Price
- VNRX $0.67
- CXH $7.54
- Analyst Decision
- VNRX Strong Buy
- CXH
- Analyst Count
- VNRX 5
- CXH 0
- Target Price
- VNRX $3.88
- CXH N/A
- AVG Volume (30 Days)
- VNRX 307.2K
- CXH 25.9K
- Earning Date
- VNRX 08-13-2025
- CXH 01-01-0001
- Dividend Yield
- VNRX N/A
- CXH 3.56%
- EPS Growth
- VNRX N/A
- CXH N/A
- EPS
- VNRX N/A
- CXH 0.23
- Revenue
- VNRX $1,308,361.00
- CXH N/A
- Revenue This Year
- VNRX $563.72
- CXH N/A
- Revenue Next Year
- VNRX $160.43
- CXH N/A
- P/E Ratio
- VNRX N/A
- CXH $33.35
- Revenue Growth
- VNRX 64.16
- CXH N/A
- 52 Week Low
- VNRX $0.40
- CXH $6.41
- 52 Week High
- VNRX $0.94
- CXH $7.74
- Technical
- Relative Strength Index (RSI)
- VNRX 48.82
- CXH 40.05
- Support Level
- VNRX $0.62
- CXH $7.58
- Resistance Level
- VNRX $0.76
- CXH $7.66
- Average True Range (ATR)
- VNRX 0.08
- CXH 0.05
- MACD
- VNRX -0.02
- CXH -0.00
- Stochastic Oscillator
- VNRX 16.73
- CXH 9.09
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About CXH MFS Investment Grade Municipal Trust
Mfs Investment Grade Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowing for investment purposes, in tax-exempt bonds and tax-exempt notes.